A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization
ConclusionsWith the described RBD-based ELISA protocol, we provide a reliable test for seroepidemiological surveys. Due to high specificity and strong correlation with virus neutralization, the RBD ELISA holds great potential to become a preferred tool to assess thresholds of protective immunity after infection and vaccination.
Source: Infection - Category: Infectious Diseases Source Type: research
More News: Coronavirus | COVID-19 | Economy | Infectious Diseases | International Medicine & Public Health | Pandemics | Respiratory Medicine | SARS | Vaccines